Literature DB >> 630787

Relationship between diazepam dose, plasma level, age, and central nervous system depression.

M M Reidenberg, M Levy, H Warner, C B Coutinho, M A Schwartz, G Yu, J Cheripko.   

Abstract

Patients undergoing elective cardioversion for treatment of arrhythmias were premedicated with diazepam. The dose was individualized to achieve a degree of central nervous system CNS) depression characterized by response to painful but not vocal stimulation. Promptly following each cardioversion, blood was drawn and the plasma diazepam concentration was measured by gas chromatography. The plasma levels varied as widely as the diazepam doses so that there was no fixed plasma level of diazepam associated with the degree of CNS depression produced in these patients. However, both the dose of diazepam and the resulting plasma level were inversely correlated to age, indicating that age is a critical factor in the use of diazepam for cardioversion premedication; elderly are more sensitive to the depressant effects of this drug than the young.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 630787     DOI: 10.1002/cpt1978234371

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  47 in total

Review 1.  Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications.

Authors:  A A Mangoni; S H D Jackson
Journal:  Br J Clin Pharmacol       Date:  2004-01       Impact factor: 4.335

2.  Bioavailability prediction based on molecular structure for a diverse series of drugs.

Authors:  Joseph V Turner; Desmond J Maddalena; Snezana Agatonovic-Kustrin
Journal:  Pharm Res       Date:  2004-01       Impact factor: 4.200

3.  Prescribing drugs for the elderly: reaching therapeutic goals.

Authors:  H G Preiksaitis; M Gordon
Journal:  Can Fam Physician       Date:  1986-12       Impact factor: 3.275

Review 4.  Clinical pharmacokinetics of anxiolytics and hypnotics in the elderly. Therapeutic considerations (Part II).

Authors:  D J Greenblatt; J S Harmatz; R I Shader
Journal:  Clin Pharmacokinet       Date:  1991-10       Impact factor: 6.447

5.  Steady state pharmacokinetics of hydrolysed bopindolol in young and elderly men.

Authors:  D Holmes; E Nuesch; J M Houle; J Rosenthaler
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

6.  Single dose pharmacokinetics and pharmacodynamics of oral oxazepam in very elderly institutionalised subjects.

Authors:  J Sonne; S Loft; M Døssing; S Boesgaard; F Andreasen
Journal:  Br J Clin Pharmacol       Date:  1991-06       Impact factor: 4.335

Review 7.  Pharmacokinetic and pharmacodynamic changes in the elderly. Clinical implications.

Authors:  A Hämmerlein; H Derendorf; D T Lowenthal
Journal:  Clin Pharmacokinet       Date:  1998-07       Impact factor: 6.447

8.  Single dose pharmacokinetics and pharmacodynamics of oral loprazolam in the elderly.

Authors:  C G Swift; M R Swift; S I Ankier; A Pidgen; J Robinson
Journal:  Br J Clin Pharmacol       Date:  1985-08       Impact factor: 4.335

9.  Hypnotic accumulation and hangover in elderly inpatients: a controlled double-blind study of temazepam and nitrazepam.

Authors:  P J Cook; A Huggett; R Graham-Pole; I T Savage; I M James
Journal:  Br Med J (Clin Res Ed)       Date:  1983-01-08

10.  Diazepam tolerance: effect of age, regular sedation, and alcohol.

Authors:  P J Cook; R Flanagan; I M James
Journal:  Br Med J (Clin Res Ed)       Date:  1984-08-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.